CURE’s rare cancers page is a go-to resource for oncology news and updates in the world of rare cancers Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in rare cancers.
Patients with neuroendocrine tumors have more treatment options than ever before.
January 26th 2021, 7:00pm
A cancer survivor writes about how he, like many, was blindsided by his diagnosis and what it was like to receive treatment for a rare disease: penile cancer.
December 16th 2020, 2:00pm
After a median follow-up of 9.9 months, 38% of the trial participants experienced some degree of tumor shrinkage after receiving Opdivo in combination with Yervoy.
October 2nd 2020, 1:00pm
New treatments are needed for penile cancer, but it’s difficult to test drugs in clinical trials because the disease is so uncommon.
September 29th 2020, 3:00pm
A woman shares her late husband’s journey with advanced penile cancer to help others receive a diagnosis early, when the disease is still highly treatable and even curable.
September 17th 2020, 3:00pm
In this episode of the “CURE Talks Cancer” podcast, we spoke with an expert about some of the possible causes of penile cancer, as well as why research in the field is severely lacking and why it’s so important to inform the public about what to look for in terms of signs and symptoms of this disease.
August 27th 2020, 3:00pm
In this week’s episode of the CURE® Talks Cancer podcast, surgical oncologist Dr. Margo Shoup sits down with CURE® to shed some light on retroperitoneal sarcoma and shares her thoughts on what patients need to know about its diagnosis and treatment.
August 26th 2020, 3:00pm
Salivary cancer is a rare disease that has some of the greatest variances of all types of cancer.
April 17th 2019, 9:06pm
The PAN Foundation today opened a new patient assistance program for people living with carcinoid syndrome.
March 20th 2018, 5:12pm
February 22nd 2018, 9:07pm
Two schools of thought exist about how to treat metastatic cancers of unidentified subtype, called carcinomas of unknown primary.
What Does Standing Up to Cancer Mean to You?
From Patient to Author: Emphasizing Shared Decision Making in NSCLC
Understanding Your Diagnosis: An Overview of Leukemia
Looking Back on the Shock of a Multiple Myeloma Diagnosis